After finishing at $0.19 in the prior trading day, Synaptogenix Inc (NASDAQ: SNPX) closed at $0.18, down -2.28%. In other words, the price has decreased by -$0.0142 from its previous closing price. On the day, 784860 shares were traded.
Ratios:
Our goal is to gain a better understanding of SNPX by taking a closer look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 17.79 and its Current Ratio is at 17.79. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, SNPX now has a Market Capitalization of 3.82M and an Enterprise Value of -26.22M.
Stock Price History:
Over the past 52 weeks, SNPX has reached a high of $1.88, while it has fallen to a 52-week low of $0.14. The 50-Day Moving Average of the stock is 0.1988, while the 200-Day Moving Average is calculated to be 0.4146.
Shares Statistics:
The stock has traded on average 792.23K shares per day over the past 3-months and 286.12k shares per day over the last 10 days, according to various share statistics. A total of 20.39M shares are outstanding, with a floating share count of 19.73M. Insiders hold about 3.24% of the company’s shares, while institutions hold 5.94% stake in the company. Shares short for SNPX as of Feb 29, 2024 were 540.33k with a Short Ratio of 0.68, compared to 171.48k on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 2.65% and a Short% of Float of 2.68%.
Earnings Estimates
Its stock is currently analyzed by 0 different market analysts. On average, analysts expect EPS of $0 for the current quarter, with a high estimate of $0 and a low estimate of $0, while EPS last year was -$0.54. The consensus estimate for the next quarter is $0, with high estimates of $0 and low estimates of $0.
Analysts are recommending an EPS of between $0 and $0 for the fiscal current year, implying an average EPS of $0. EPS for the following year is $0, with 0 analysts recommending between $0 and $0.
